Matrixrib
Device CMF-Trauma
PDI 10887587074382
General payments
$2,100,200
Research payments
$157,210
Through program year 2025, $2,100,200 in general payments and $157,210 in research payments were reported against Matrixrib (CMF-Trauma).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $338,142 | 841 |
| 2024 | General | $391,641 | 799 |
| 2023 | General | $468,558 | 924 |
| 2023 | Research | $41,475 | 1 |
| 2022 | General | $473,240 | 661 |
| 2022 | Research | $115,735 | 2 |
| 2021 | General | $428,619 | 581 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,806 general · 3 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.